MeTA 19: National Forum 2015, Empowerment of Patients

The two-days annual national forum of the Medicines Transparency Alliance (MeTA) Philippines started today. I attended the afternoon session only because I attended the w FNF event at The Mind Museum, Fort Bonifacio.

Here is the program.

Daty 1, February 17

SESSION 1:  OPENING OF THE 2015 FORUM

ACCESS AND EQUITY: MAKING HEALTHCARE A REALITY FOR ALL

1. Invocation, Ms. Precy Declaro-Deluria,

Executive Director, Philippine Cerebral Palsy, Inc.

2. Overview of the Forum, Ms. Cecilia C. Sison, Country Coordinator, MeTA Philippines

Opening Message, Mr. Roberto M. Pagdanganan, Chairman of MeTA Philippines

3. Remarks from the International MeTA Secretariat

Ms. Deirdre Dimancesco, Technical Officer - Department of Essential Medicines, World Health Organization (WHO)

Dr. Tim Reed, Executive Director, Health Action International (HAI)

4. Message of the Department of Health (DOH)

Atty. Nicolas B. Lutero III, OIC, FDA; Director, Legal Services, DOH

5. Keynote Speech, Dr. Julie Lyn Hall, MBE, WHO Representative to the Philippines

SESSION 2: EMPOWERMENT, ENGAGING PATIENTS IN THE DIALOGUE ON HEALTH

6. Stakeholder Mapping and Development of a Framework for the Engagement and Empowerment of Patient Organizations in the Philippines

Mr. Wadel S. Cabrera III, WHO / MeTA Project Consultant

7. Panel Discussion

Moderator: Dr. Noel R. Juban, Professor, UP College of Medicine

(a) Ms. Deirdre Dimancesco, Technical Officer - Department of Essential Medicines, WHO

(b) Dr. Maria Minerva P. Calimag, President, Philippine Medical Association (PMA)

(c) Mr. Teodoro B. Padilla, Executive Director, Pharmaceutical and Healthcare Association of the Philippines (PHAP)

(d) Engr. Emer Rojas, President, New Vois Association of the Philippines

(e) Dr. Benjamin Bernardino, Secretary General, Life Haven Independent Living Center

(f) Ms. Salvacion Basiano, President, Center for Empowerment and Development of the Elderly and Seniors

(photo below, during the MeTA national forum 2014, held at Bayanihan Center, Unilab Complex, Pasig City)

SESSION 3: MULTISTAKEHOLDER COLLABORATION, HEALTH AND MEDICINES FOR THE FILIPINO PATIENT

8. Panel Discussion – Part 1 (Access to Medicines)

Moderator: Mr. Tomas Marcelo Luke G. Agana III,  Adviser, Philippine Chamber of  the Pharmaceutical Industry (PCPI)

(a) Drug Price Watch / Electronic Drug Price Monitoring System (EDPMS) / Drug Price Reference Index (DPRI)
by Mark Haasis, National Center for Pharmaceutical Access and Management (NCPAM), DOH

(b) Rational Use of Medicines (RUM) Framework / Antimicrobial Resistance (AMR) Policy,

by Dr. Anna Melissa S. Guerrero, Program Manager, NCPAM, DOH

(c) Combating SSFFC (substandard, spurious, falselylabeled, falsified, counterfeit) medical products / Coalition for Safe Medicines, 

by Ms. Maria Lourdes C. Santiago, RPh (invited), Director, Center for Drug Regulation and Research, Food and Drug Administration (FDA)

(d) Pharmaceutical Transparency Through Technology (PTTT) / LUNAS mobile app, 

by Dr. Bryan Albert Lim, Founding Partner, Health Sector Catalyst

(e) Tamang Serbisyo para sa Kalusugan ng Pamilya (TSeKaP) / Z Benefits 

by Dr. Rizza Majella L. Herrera,  Head, PCB/TSeKaP Team, Philippine Health Insurance Corporation (PhilHealth)

(f) Local government initiatives to address medicine needs of its constituents and the community 

by Hon. Gerardo V. Calderon (invited), Mayor, Municipality of Angono, Rizal

(g) Training Modules on Supply Chain Management (SCM) / Philippine Practical Standards for Pharmacists (PhilPSP)

by Mr. Roderick L. Salenga, NPO (EDM), WHO Country Office

Day 2, February 18

SESSION 4:  STAKEHOLDER PERSPECTIVES

10. Stakeholder Workshops

Moderator: Ms. Cecilia C. Sison,  Country Coordinator,  MeTA Philippines

Group Facilitators:

 Mr. Ralph Emerson P. Degollacion

 Dr. Irene F. Farinas

 Mr. Manuel Alexander Haasis

 Dr. Elenita Loida A. Pedrosa

 Ms. Karen A. Villanueva

SESSION 5:  SHARING STAKEHOLDER INSIGHTS

Invocation Ms. Maria Zenaida J. Averilla, Founder / CEO, Scleroderma Society of the Philippines

Reports on the Day 1 Stakeholder Workshops

11. SESSION 6: ACCOUNTABILITY,  FOLLOWING THE MONEY SPENT ON KEY HEALTH PROGRAMS

(a) Medicines Watch, by Dr. Elmer S. Soriano, MeTA / CHAT Project Consultant, Civika Institute

(b) Philhealth Watch, by Mr. Rene R. Raya, MeTA / CHAT Project Consultant, Action for Economic Reform

(c) Sin Tax Monitoring Tool, by Ms. Marian Theresia R. Valera, Consultant, HealthJustice Philippines

12. Lunch / Civil Society Meeting with the IMS

Panel Discussion

Moderator: Mr. Roderick L. Salenga,  NPO (EMD),  WHO Country Office

(a) Asst. Sec. Elmer G. Punzalan, MD (invited), Head, Office for Health Regulation, DOH

(b) Ruben John A. Basa, Senior Vice President, Health Finance Policy Group, PhilHealth

(c) Ms. Teofila E. Remotigue, CEO, National Pharmaceutical Foundation, Inc., Coalition for Health Advocacy and Transparency

SESSION 7:  SUSTAINABILITY, BUILDING ON THE GAINS AND MOVING FORWARD

13. Response of The Filipino Patient 

Mr. Josefino de Guzman, President, Psoriasis Philippines;

Ms. Maria Fatima G. Lorenzo, President, Philippine Alliance of Patient Organizations

Synthesis and Closing Remarks 

Mr. Roberto M. Pagdanganan, Chairman, MeTA Philippines

------------

See also:
MeTA 15: Forum 2014 on Healthcare Ethics and Transparency, January 30, 2014 

MeTA 16: Day 1 of Conference 2014, February 11, 2014 

MeTA 17: CHAT General Assembly, March 2014, March 31, 2014 

MeTA 18: More Financial Independence, More Stakeholders Participation, December 11, 2014

ETHIKOS 2: Pharma Companies and Patients, April 01, 2014